ROBERT C SCHROEDER Insider Trading $AKER MyMD Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT C SCHROEDER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT C SCHROEDER. ROBERT C SCHROEDER is Director in SCOLR Pharma, Inc. ($SCLL.OB) and Director in AIR INDUSTRIES GROUP ($HNNS.OB) and Director in INTELLINETICS, INC. ($INLX) and Director in Akers Biosciences, Inc. ($AKER) and Director in DecisionPoint Systems, Inc. ($DPSI) and Director in DecisionPoint Systems, Inc. ($DPSI).
ROBERT C SCHROEDER in MyMD Pharmaceuticals, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of ROBERT C SCHROEDER: Director
Holdings: 43,930 shares
Current Value: $54,913
Latest Transaction: Apr 20 2021
$AKER Market Capitalization: $6.82M
$AKER Previous Close: $1.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT C SCHROEDER in MyMD Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AIRI, DPSI, DPSI, INLX, AKER, SCLL.OB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 20 2021 | AKER | MyMD Pharmaceutica ... | SCHROEDER ROBERT C | Director | Option Exercise | M | 0.00 | 43,930 | 0 | 0 | |
| Apr 20 2021 | AKER | MyMD Pharmaceutica ... | SCHROEDER ROBERT C | Director | Payment of Exercise | F | 4.94 | 14,694 | 72,588 | 29,236 | 43.9 K to 29.2 K (-33.45 %) |
| Apr 20 2021 | AKER | MyMD Pharmaceutica ... | SCHROEDER ROBERT C | Director | Buy | M | 0.00 | 43,930 | 0 | 43,930 | 0 to 43.9 K |
| Apr 20 2021 | AKER | MyMD Pharmaceutica ... | SCHROEDER ROBERT C | Director | Option Exercise | M | 0.00 | 43,930 | 0 | 0 | |
| Apr 20 2021 | AKER | MyMD Pharmaceutica ... | SCHROEDER ROBERT C | Director | Payment of Exercise | F | 4.94 | 14,694 | 72,588 | 29,236 | 43.9 K to 29.2 K (-33.45 %) |
| Apr 20 2021 | AKER | MyMD Pharmaceutica ... | SCHROEDER ROBERT C | Director | Buy | M | 0.00 | 43,930 | 0 | 43,930 | 0 to 43.9 K |
| Sep 11 2020 | AKER | Akers Biosciences, ... | SCHROEDER ROBERT C | Director | Option Exercise | A | 0.00 | 87,860 | 0 | 87,860 |
Page: 1